|
| Exchange Disseminated Time 11/10/2016 08:07:55 | Piramal Enterprises Ltd has submitted to BSE a copy of the Press Release being issued by the Company on the agreement to acquire five anesthesia and pain management injectabic products from Janssen Pharmaceutica NV in an all cash deal for an upfront consideration of US$155 million, and up to an additional US$20 million, by its wholly-owned subsidiary in the UK, Piramal Critical Care Limited.
A copy of the presentation being circulated to the Investors and Analysts in this regard is also attached.
No related party of Piramal Enterprises Limited has any interest in the aforesaid transaction. |
|
|